Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2024

SuperCom Ltd. (NASDAQ: SPCB) Secures New $1.8 Million Contract with a Trusted Long-Term Government Customer

Secured electronic and digital solutions innovator SuperCom (NASDAQ: SPCB) recently announced that it has secured a new $1.8 million contract with a long-standing customer of its e-Government division, showcasing the company’s continued competitiveness and the values that help it retain … Continue reading

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks – McEwen Mining (NYSE: MUX) (TSX: MUX) Reports Attractive Gold Grades at Grey Fox, Strengthened Potential for Open Pit Mining

McEwen Mining (NYSE: MUX) (TSX: MUX) yesterday announced promising new assay results from the Grey Fox deposit within its Fox Complex. The highlights include significant gold grades at both shallow and deeper levels, suggesting potential for low-cost open pit mining … Continue reading

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Join Russell 3000 Index in July

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, announced that it will be joining the broad-market Russell 3000® Index at the conclusion of the … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Developing Zero-Emissions Version of Its PowerUP Mobile EV-Charging Truck

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is developing a zero-emissions version of its mobile EV-charging solution, PowerUP. The solution will be available on Mullen’s Class 3 all-electric cab chassis truck. According to the announcement, PowerUp provides increased … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 (https://ibn.fm/74Pee). This follows the recent announcement of an applied research program to evaluate certain molecular … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Growing EM Applications as America Adopts Ankle Monitors for Asylum Seekers

SuperCom (NASDAQ: SPCB), a global leading provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments, is steadily advancing its technologies, primarily given the growing use case for electronic monitoring (“EM”) solutions … Continue reading

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Stands out as Key Player in Basic Materials Space

McEwen Mining (NYSE: MUX) (TSX: MUX) has been a standout performer in the basic materials sector this year, showcasing a remarkable growth trajectory that has caught the attention of investors and analysts alike. “With a year-to-date stock price increase of … Continue reading

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces GAMA as First Distributor for the Balkans Region of Southeastern Europe

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced GAMA as a new European distribution partner. GAMA will offer the company’s full commercial EV product lineup in the Balkans Region of southeastern Europe, which includes Bosnia Herzegovina, … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease, recently participated in three investor conferences during May … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

PaxMedica (NASDAQ: PXMD), a biopharmaceutical firm dedicated to advancing treatments for neurological disorders, recently announced that it has received an urgent plea from the Ministry of Health (“MOH”) of Malawi. The MOH is requesting emergency access to IV suramin to … Continue reading

Posted in PaxMedica Inc. PXMD | Leave a comment